Source: Annual Congress 2003 - Clinical pathobiology in diffuse and in neoplastic disorders
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
H. Golpon, T. Koehnlein, N. Dickgreber, S. Maas, T. Welte (Magdeburg, Germany). Diminished expression of HOXA5 in lung cancer. Eur Respir J 2003; 22: Suppl. 45, 1683

Member's Comments

No comment yet.

Related content which might interest you: CD44v6 expression in tissue of patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004 ASCL1 suppress ZFP36L1 expression by regulating miR124-3p expression in lung adenocarcinoma Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Expression of HOXA5 and p53 in fetal and adult human lung Source: Eur Respir J 2004; 24: Suppl. 48, 4s Year: 2004 Over-expression of aquaporin-5 increases migration and metastatic potential of lung cancer cells Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Evaluation expression of miR-146a and miR-155 and inflammatory  cytokines in blood of non-small cell lung cancer patients Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Survivin expression in non-small cell lung cancer Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Correlation of miR-422a, miR-21 and miR-155 analysis with hMSH2 and hMLH1 mRNA expression profiles in non-small cell lung carcinomas and their adjacent normal tissues Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Transcriptional regulation of the human osteopontin promoter in non-small cell lung cancer Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011 Mutant P53 expression in squamous cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002 Abnormal expression of let-7a miRNA in blood of lung cancer patient Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumour metastasis Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Expression of Her-2/neu and Bcl-2 in patients with non-small cell lung cancer Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017 Where next for lung cancer gene expression profiling? Source: Eur Respir J 2007; 30: 5-6 Year: 2007 Importance of clusterin expression at tissue level for the prognosis of non-small cells lung cancer Source: Annual Congress 2009 - Lung cancer biology Year: 2009 Profile of WT1 methylation in human lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Expression of MAGE in the induced sputum of lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 595s Year: 2002 Expression of ERCC1 in normal and tumor tissues in non-small cell lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 MicroRNA-101 inhibits lung cancer growth and invasion through regulation of EZH2 Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer Source: Eur Respir J 2013; 41: 1172-1178 Year: 2013 HER-2/neu oncoprotein expression in nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002